FIELD: chemistry; medicine.
SUBSTANCE: invention relates to biochemistry, immunology and medicine, in particular to polypeptides containing an antigen-binding domain and a transporting fragment having an inhibitory domain, which inhibits the antigen-binding activity of the antigen-binding domain and has a longer half-life compared to the antigen-binding domain in its individual form, a method of producing polypeptides, pharmaceutical compositions containing a polypeptide.
EFFECT: disclosed polypeptides enable to provide recovery of antigen-binding domain of its antigen-binding activity in diseased tissues and manifestation of antigen-binding activity in diseased tissues.
14 cl, 31 dwg, 23 tbl, 16 ex
Title | Year | Author | Number |
---|---|---|---|
PROPERDIN ANTIBODIES AND PRODUCTION THEREOF | 2021 |
|
RU2830308C1 |
CHIMERIC CYTOKINE RECEPTORS CARRYING PD-1 ECTODOMAIN | 2020 |
|
RU2828214C2 |
ANTIGENIC PEPTIDES FOR PREVENTION AND TREATMENT OF B-CELL HEMOBLASTOSIS | 2020 |
|
RU2833806C1 |
POLYPEPTIDE COMPRISING ANTIGEN-BINDING DOMAIN AND TRANSPORT SEGMENT | 2018 |
|
RU2815452C2 |
POLYPEPTIDE COMPRISING ANTIGEN-BINDING DOMAIN AND TRANSPORT SEGMENT | 2017 |
|
RU2827545C2 |
MONOCLONAL ANTIBODIES AGAINST THE RECEPTOR-BINDING DOMAIN OF SARS-COV-2 SPIKE PROTEIN AND THEIR ANTIGEN-BINDING FRAGMENTS ENCODING THEIR NUCLEIC ACIDS, AS WELL AS METHODS OF THEIR USE | 2021 |
|
RU2800649C2 |
BISPECIFIC ANTIBODIES AND THEIR APPLICATIONS | 2022 |
|
RU2821577C2 |
METHOD OF PRODUCING AMINO ACID SEQUENCES CODING NANOANTIBODIES NEUTRALIZING CLOSTRIDIOIDES DIFFICILE A TOXIN | 2023 |
|
RU2833930C1 |
BCMA-SPECIFIC CHIMERIC ANTIGEN RECEPTORS CONTAINING IL-6 SIGNALLING BLOCKER | 2023 |
|
RU2828294C1 |
IDE ANTIBODIES AND USE THEREOF | 2020 |
|
RU2839026C1 |
Authors
Dates
2025-06-09—Published
2018-11-28—Filed